All News
Activist shareholder targets Ashland
Andrew Warmington
ECHA establishes alternative testing platform
Andrew Warmington
Chemservice buys EBRC
Andrew Warmington
CBE JU announces annual grants
Andrew Warmington
Givaudan takes control at Eurofragance
Andrew Warmington
UPM in IP deal
Andrew Warmington
CordenPharma buys AmbioPharm
Andrew Warmington
Evonik in mining chemical partnership
Andrew Warmington
Wacker sells part of Siltronic
Andrew Warmington
Symrise breaks ground
Andrew Warmington
Kemira in PFAS removal first
Andrew Warmington